LFTD Partners Inc.
- Close
- Oct 13, 2025
- Market cap
- $3.71M
- 14.82M shares
- Filings
- 261
Q3 2026−1.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−17.7% FY25 yoy
- $3.71M
- —
- 0.1×
- 1.0×
- 17.67%
- —
Twelve months to Sep 30, 2026 · derived
Price
Oct 13, 2025 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $36,920,799 | reported | |
| FY 2024 | 2024-12-31 | $37,325,228 | reported | |
| FY 2023 | 2023-12-31 | $51,610,562 | reported | |
| FY 2022 | 2022-12-31 | $57,416,535 | reported | |
| FY 2021 | 2021-12-31 | $31,656,932 | reported | |
| FY 2020 | 2020-12-31 | $5,344,320 | reported | |
| FY 2019 | 2019-12-31 | $0 | reported | |
| FY 2012 | 2012-12-31 | $250,400 | reported | |
| FY 2011 | 2011-12-31 | $460,496 | reported | |
| FY 2010 | 2010-12-31 | $4,851,190 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $0.00 | $0.00 | — | 14.82M sh | ±0.0% | 0.0% |
| FY2024 | — | $240.24K | $240.24K | — | 14.82M sh | +0.1% | — |
| FY2023 | — | $0.00 | $0.00 | — | 14.81M sh | +2.0% | — |
| FY2022 | — | $150.00K | $150.00K | — | 14.51M sh | +3.8% | 7.1% |
| FY2021 | $11.84K | $34.20K | $46.04K | — | 13.98M sh | +43.2% | 0.9% |
Segments
Products
LineFY2023ShareChange
Distributors$36.72M71%−19.3%
Wholesalers$10.73M21%+43.0%
Flower$5.19M10%+6.7%
Cartridges$4.14M8.0%−44.6%
Non-Hemp Products$3.55M6.9%+105.9%
End Consumers$2.47M4.8%−26.7%
Private Label Clients$1.50M2.9%+53.9%
Other$287.21K0.6%+72.5%
Total$51.61M
Pharmaceutical preparations
LFTD Partners Inc. is the 139th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
WVEWave Life Sciences, Inc.$42.7M60.5%478.3%$622.3MBFRIBiofrontera Inc.$41.7M11.7%25.3%$16.9MBGMBGM Group Ltd.$37.9M51.1%52.6%—
LIFDLFTD Partners Inc. (this company)$36.9M1.1%67.3%$3.7M
SBFMSunshine Biopharma Inc.$36.3M4.1%16.5%$2.4METSTEarth Science Tech, Inc.$35.7M7.8%10.2%$25.8MVRCAVerrica Pharmaceuticals Inc.$35.6M370.2%50.3%$52.9MBHSTBioharvest Sciences Inc.$34.5M37.0%32.3%$39.7MZOMDFZomedica Corp.$32.0M17.4%255.6%$78.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
LFTD Partners Inc. · CIK 1391135 · Engraved from SEC EDGAR